SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-209441
Filing Date
2012-05-04
Accepted
2012-05-03 21:31:33
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d311622d10q.htm 10-Q 497411
2 PURCHASE AND SALE AGREEMENT d311622dex101.htm EX-10.1 292627
3 CERTIFICATION OF NEKTAR THERAPEUTICS PRINCIPAL EXECUTIVE OFFICER d311622dex311.htm EX-31.1 9760
4 CERTIFICATION OF NEKTAR THERAPEUTICS PRINCIPAL FINANCIAL OFFICER d311622dex312.htm EX-31.2 9759
5 SECTION 1350 CERTIFICATIONS d311622dex321.htm EX-32.1 5014
  Complete submission text file 0001193125-12-209441.txt   3741947

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nktr-20120331.xml EX-101.INS 484776
7 XBRL TAXONOMY EXTENSION SCHEMA nktr-20120331.xsd EX-101.SCH 38644
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20120331_cal.xml EX-101.CAL 44614
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20120331_def.xml EX-101.DEF 71969
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20120331_lab.xml EX-101.LAB 275059
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20120331_pre.xml EX-101.PRE 196574
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 12811691
SIC: 2834 Pharmaceutical Preparations